ִҵҩʦҩѧ³£ÓÃÓһ£©
ִҵҩʦ×ʸñ¿¼ÊÔҩѧ×ÛºÏ֪ʶÓë¼¼ÄÜ£ºÒ©Ñ§³£ÓÃÓһ£©
°²È«·¶Î§ safety range
°²È«ÊÔÑé·¨ innocuity test method
°²È«ÏµÍ³ safety coefficient
°²Î¿¼Á placebo
òüºÏ¼Á chelating agent
°Ðϸ°û target cell
°×µ°°×΢ÇòÖÆ¼Á albumin microballoons
°Ù·ÖŨ¶È percentage concentration
°ëºÏ³É¿¹ÉúËØ semisynthetic antibiotics
°ë¿¹Ô haptene
°ëÊýÖÂËÀ¼ÁÁ¿ half lethal dose £» median lethal dose£» LD50
°ëË¥ÆÚ half-life period£» half life time
°üÒÂÆ¬ coated tablet
±¡Ä¤Ò film-coating
±¥ºÍÈÜÒº saturated solution
±´¿ËÀÕ¶û Becquerel
±»¶¯ÃâÒß passive immunity
±»¶¯×ªÔË passive transport
±À½â¶È disintegration
±À½â¼Á disintegrants
¸ü¶àÅàѵ¿Î³Ì£¬Ñ§Ï°×ÊѶ£¬¿Î³ÌÓŻݵÈѧУÐÅÏ¢£¬Çë½øÈë ±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦Åàѵ±±¾©¶«³ÇÇøÖ´ÒµÒ½Ê¦Åàѵ ÍøÕ¾ÏêϸÁ˽⣬Ãâ·Ñ×Éѯµç»°£º400-998-6158

±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦ÅàѵµØÖ·ÔÚÄÄ

±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦ÅàѵÊշѱê×¼

±±¾©¶«³ÇÇøÄÄÀïÓÐִҵҩʦÅàѵ°à

±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦Åàѵ»ú¹¹ÄĸöÇ¿

±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦Åàѵ·ÑÓöàÉÙ

±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦Åàѵ°à±¨¿¼Ìõ¼þ

±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦ÅàÈçºÎÊÕ·Ñ

±±¾©¶«³ÇÇøÖ´ÒµÒ©Ê¦ÅàѵÔõôÊÕ·Ñ

±±¾©¶«³ÇÇøÖ´ÒµÒ½Ê¦ÅàѵÄĸöÇ¿

±±¾©¶«³ÇÇøÖ´ÒµÒ½Ê¦ÅàѵÔõôÊÕ·Ñ


